Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-02-22 @ 4:14 PM
Study NCT ID:
NCT02859259
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2016-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-28
First Submit QC Date:
None
Study First Post Date:
2016-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-12
Last Update Post Date:
2017-05-15
Last Update Post Date Type:
ACTUAL